Unlocking the Future of the COVID-19 Saliva Screening Test Potential Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the covid-19 saliva screening test potential market right now?
The COVID-19 saliva screening test potential market has expanded strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.9%. This growth is due to the potential for home testing, the unprecedented need for diagnostic testing, rising public awareness, and increased investment in research and development.
How fast Is the covid-19 saliva screening test potential market expected to grow, and what’s its future value?
The COVID-19 saliva screening test market is expected to grow to $6.17 billion by 2029, at a CAGR of 9.5%. Growth is attributed to the integration of screening programs, regulatory support, demand for rapid point-of-care tests, population growth, and e-commerce. Trends include increased adoption in non-healthcare settings, digital health platform integration, next-gen technologies, technological advancements, and strategic partnerships.
Get your covid-19 saliva screening test potential market report here!
What are the leading drivers of growth in the covid-19 saliva screening test potential market?
The growing healthcare expenditure is expected to spur the growth of the COVID-19 saliva screening test market. Healthcare expenditure refers to the total spending on healthcare services and products, including prescription medications, hospital stays, doctor visits, medical devices, and public health campaigns. Factors like minimally invasive surgeries, advanced diagnostic technologies, and increased investment in R&D for new drugs contribute to the rise in healthcare spending. This financial growth supports the broader use of COVID-19 saliva screening tests, enhancing pandemic control efforts and improving health outcomes. For instance, in 2022, the UK’s healthcare expenditure reached $354.88 billion (£283 billion), marking a 0.7% increase from 2021, according to the Office for National Statistics. This surge in healthcare spending supports the growth of the COVID-19 saliva screening test market.
What are the key segments defining the covid-19 saliva screening test potential market?
The COVID-19 saliva screening test potential market covered in this report is segmented –
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing
Subsegments:
1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas
6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites
7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp
Who are the key players steering the development of the covid-19 saliva screening test potential market?
Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.
What emerging trends are influencing the growth of the covid-19 saliva screening test potential market?
Companies in the COVID-19 saliva screening test market are developing data-sharing platforms to enhance communication and collaboration in testing and tracking. In May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. This initiative focuses on improving public health emergency responses, ensuring efficient strategies during pandemics and other crises.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16026
Which regions are most influential in expanding the covid-19 saliva screening test potential market?
North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Blood Screening Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report
Carrier Screening Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report
Cellular Health Screening Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
